e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Thoracic oncology: rare tumours and metastases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung cancer as secondary malignance
D. Z. Kocic, D. Dacic, I. Djordjevic (Yugoslavia)
Source:
Annual Congress 2002 - Thoracic oncology: rare tumours and metastases
Session:
Thoracic oncology: rare tumours and metastases
Session type:
Thematic Poster Session
Number:
2942
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Z. Kocic, D. Dacic, I. Djordjevic (Yugoslavia). Lung cancer as secondary malignance. Eur Respir J 2002; 20: Suppl. 38, 2942
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Lung cancer
Source: Virtual Congress 2020 – Impact in children and in adults with premorbid respiratory disease (acute and long-term)
Year: 2020
Lung cancer
Source: Breathe 2016; 12: 392-399
Year: 2016
Lung cancer
Source: School Course 2014 - Pulmonary Rehabilitation
Year: 2014
Lung cancer as a second primary
Source: Eur Respir J 2007; 30: Suppl. 51, 430s
Year: 2007
Breast metastasis from primary EGFR-mutated lung carcinoma or primary tumor?
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Lung cancer patients
Source: Eur Respir Monogr 2021; 90: 165-180
Year: 2021
Evaluation of lung cancer patients with distant organ metastasis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Lung cancer screening
Source: International Congress 2017 – Chinese Programme 2017
Year: 2017
Lung cancer screening
Source: Guideline 2015
Year: 2015
Lung cancer screening
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Prognostic impact of secondary malignancies in non-small cell lung cancer (NSCLC)
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Lung cancer immunotherapy
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept